Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

25
The Zacks Analyst Blog Highlights: M&T Bank, Customers Bancorp, Metropolitan Bank Holding and Triumph Bancorp

2018-07-11 zacks
Chicago, IL – July 11, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include M&T Bank Corp. (MTB - Free Report) , Customers Bancorp, Inc. (CUBI - Free Report) , Metropolitan Bank Holding Corp. (MCB - Free Report) and Triumph Bancorp, Inc.
LPLA WFCNP MOV HBANN RF.PRB HBANO HBANP RF.PRA IBKR WFC.PRL CUBS RF MOVAA WFC.PRJ SFIX LSTR HOLI FITBI CUBI.PRC CUBI.PRD CUBI.PRE CUBI.PRF WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TBK STI-A MCB STI.PRE WFC.PRY WFC.PRX WFC.PRW WFC.PRV SCHW.PRBCL WFC WFC.WS STI.WS.B STI.WS.A SCHN HBAN STI CUBI FITB PETS URBN

19
4 Top Bank Stocks to Buy Ahead of Q2 Earnings

2018-07-11 investorplace
While banks are gearing up for the Q2 earnings season, the Federal Reserve has given clean bills of health to majority of the large American banks. Strong jobs numbers, in fact, raised the possibility of further rate hikes which bodes well for banks.
WFCNP HBANN RF.PRB HBANO HBANP RF.PRA WFC.PRL MTB CUBS RF WFC.PRJ FITBI CUBI.PRC CUBI.PRD CUBI.PRE CUBI.PRF WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TBK STI-A MCB STI.PRE WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS STI.WS.B STI.WS.A HBAN STI JPM CUBI FITB

46
Discover Financial to Return More Capital, Passes Stress Test

2018-07-02 zacks
Discover Financial Services (DFS - Free Report) recently announced that it has been notified by the Board of Governors of the Federal Reserve System that the regulatory body has no objections to the company’s capital actions through Jun 30, 2019. Per the company’s capital plan, it would increase its next quarterly dividend from 35 cents to 40 cents per share of common stock. During the four quarters ending Jun 30, 2019, it has also approved a share repurchase of up to $1.
COF.PRG HBANN COF.PRH HBANO DFS HBANP COF-P COF.WS COF.PRP COF HBAN COF-D DFS.PRB DFS.PRBCL COF-C COF-F COF.PRC COF.PRD COF.PRF

45
Deutsche Bank Says Stress Test Results Positive for Banks: 3 to Buy Now

2018-07-02 247wallst
One sector that was absolutely demolished in the most recent quarter was the financials, and with second-quarter earnings right around the corner, there could be some very positive tailwinds for the sector as we start the third quarter. With the market seemingly in a very precarious position, despite the fact that the economy looks to be in the best shape in years, banks may be an outstanding buy.
WFCNP HBANN HBANO HBANP DB WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN STI-A STI.PRE WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS STI.WS.B STI.WS.A HBAN STI

91
These stocks have the highest dividend yields of the stress-test passers - MarketWatch

2018-06-30 marketwatch
If you’re looking for a high-yielding bank stock, among those most likely to survive the next financial meltdown, check out Huntington Bancshares Inc. and KeyCorp.
WFCNP HBANN HBANO HBANP GS.PRB WFC.PRL GS.PRA WFC.PRJ WFC.PRT GS WFC.PRR GLSSP WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS JBK GSC GS.PRICL TFG GSJ HBAN GS.PRJ GS.PRI GS.PRD GS.PRC GJS GS.PRN GS.PRK

211
Banks hike dividends, buybacks after Fed stress test - MarketWatch

2018-06-28 marketwatch
Several banks announced plans to return capital to shareholders late Thursday after the Federal Reserve released results of its annual stress test. J.P. Morgan Chase & Co. JPM, +1.64% said it will increase its quarterly dividend to 80 cents a share from 56 cents a share and buy back up to $20.7 billion in stock. American Express Co. AXP, +0.01% will hike its quarterly dividend 11% to 39 cents a share and buy back up to $3.
HBANN HBANO HBANP C.WSA COF.WS GS.PRB GS.PRA RF GLSSP JBK COF-P TFG GS.PRJ GS.PRI GS.PRD CGBBW GS.PRC GS.PRN GS.PRK COF.PRG WFCNP COF.PRH RF.PRB RF.PRA WFC.PRL COF.PRP WFC.PRJ COF-D WFC.PRT GS COF-C C.WS.B COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF C.PRS WFC WFC.WS C.PRL C GSC GS.PRICL C.PRJ C.PRK COF C.PRG GSJ C.PRC HBAN C.PRPCL GJS

103
Fed limits payouts at Goldman Sachs, Morgan Stanley, again faults Deutsche Bank - MarketWatch

2018-06-28 marketwatch
The Federal Reserve on Thursday announced that it rejected the capital plan of the U.S. arm of Deutsche Bank for the third time in four years as it also limited the payouts of Wall Street trading giants Goldman Sachs and Morgan Stanley.
WFCNP HBANN HBANO HBANP DB STT.PRC STT.PRE NTRSP STT.PRD STT.PRG MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA WFC.PRT ALLY.PRA WFC.PRR WFC.PRQ WFC.PRP NTRS WFC.PRO WFC.PRN STI-A STI.PRE WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS STT STI.WS.B STI.WS.A PNC.PRP PNC.PRQ PNCFO HBAN PNC.WS STI MS.PRI ALLY MS.PRK PNC PNUCL SOV.PRC

313
RPT-Bank investors await U.S. stress test results for capital returns

2018-06-21 reuters
NEW YORK, June 21 (Reuters) - U.S. investors expect banks and other financial institutions to announce large returns of capital to shareholders after the Federal Reserve publishes the first set of results from its annual “stress test” late Thursday.
HBANN HBANO HBANP C.WSA COF.WS GS.PRB GS.PRA RF FITBI CFIN ALLY.PRA GLSSP CIWV NTRS STI-A CIT JBK STI.WS.B STI.WS.A DFS COF-P CMA TFG GS.PRJ GS.PRI STI GS.PRD CGBBW GS.PRC FITB GS.PRN GS.PRK COF.PRG WFCNP COF.PRH RF.PRB CMA.WS RF.PRA NTRSP WFC.PRL COF.PRP WFC.PRJ CMPWW DFS.PRB COF-D WFC.PRT GS COF-C DFS.PRBCL C.WS.B COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP STI.PRE C.PRU WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF C.PRS WFC WFC.WS C.PRL C GSC GS.PRICL C.PRJ C.PRK COF C.PRG GSJ C.PRC HBAN CFG ALLY C.PRPCL GJS

314
Bank investors await U.S. stress test results for capital returns

2018-06-21 reuters
NEW YORK (Reuters) - U.S. investors expect banks and other financial institutions to announce large returns of capital to shareholders after the Federal Reserve publishes the first set of results from its annual “stress test” late Thursday.
HBANN HBANO HBANP C.WSA COF.WS GS.PRB GS.PRA RF FITBI CFIN ALLY.PRA GLSSP CIWV NTRS STI-A CIT JBK STI.WS.B STI.WS.A DFS COF-P CMA TFG GS.PRJ GS.PRI STI GS.PRD CGBBW GS.PRC FITB GS.PRN GS.PRK COF.PRG WFCNP COF.PRH RF.PRB CMA.WS RF.PRA NTRSP WFC.PRL COF.PRP WFC.PRJ CMPWW DFS.PRB COF-D WFC.PRT GS COF-C DFS.PRBCL C.WS.B COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP STI.PRE C.PRU WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF C.PRS WFC WFC.WS C.PRL C GSC GS.PRICL C.PRJ C.PRK COF C.PRG GSJ C.PRC HBAN CFG ALLY C.PRPCL GJS

314
Bank investors await U.S. stress test results for capital returns

2018-06-21 reuters
NEW YORK, June 21 (Reuters) - U.S. investors expect banks and other financial institutions to announce large returns of capital to shareholders after the Federal Reserve publishes the first set of results from its annual “stress test” late Thursday.
HBANN HBANO HBANP C.WSA COF.WS GS.PRB GS.PRA RF FITBI CFIN ALLY.PRA GLSSP CIWV NTRS STI-A CIT JBK STI.WS.B STI.WS.A DFS COF-P CMA TFG GS.PRJ GS.PRI STI GS.PRD CGBBW GS.PRC FITB GS.PRN GS.PRK COF.PRG WFCNP COF.PRH RF.PRB CMA.WS RF.PRA NTRSP WFC.PRL COF.PRP WFC.PRJ CMPWW DFS.PRB COF-D WFC.PRT GS COF-C DFS.PRBCL C.WS.B COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP STI.PRE C.PRU WFC.PRY COF.PRC WFC.PRX COF.PRD WFC.PRW WFC.PRV COF.PRF C.PRS WFC WFC.WS C.PRL C GSC GS.PRICL C.PRJ C.PRK COF C.PRG GSJ C.PRC HBAN CFG ALLY C.PRPCL GJS

52
Huntington Continues to Grow Inorganically, Costs Increase

2018-06-11 zacks
On Jun 8, we issued an updated research report on Huntington Bancshares Incorporated (HBAN - Free Report) . The company continues to benefit from sound organic and inorganic growth strategies. However, mounting expenses and lack of diversification in loan portfolio remain key concerns.
WFCNP HBANN HBANO HBANP FMNB WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO ASB.WS WFC.PRN WFC.PRY WFC.PRX ASB.PRD ASB.PRC WFC.PRW WFC.PRV WFC WFC.WS ASB-D ASB-C FRME HBAN ASB

8
Huntington Bancshares: A Solid Dividend Investment

2018-05-16 seekingalpha
Ohio and other Rust Belt states are outperforming the US economy in terms of job growth, a good sign for this regional bank.
HBAN HBANN HBANO HBANP

23
BOK Financial (BOKF) Stock Gains 1.56% on Q1 Earnings Beat

2018-04-26 zacks
Shares of BOK Financial (BOKF - Free Report) inched up nearly 1.56%, following the release of first-quarter 2018 results. The company recorded positive earnings surprise of 5.9%. Earnings per share of $1.61 outpaced the Zacks Consensus Estimate of $1.52. Further, the bottom line compared favorably with $1.35 in the prior-year quarter. Top-line strength was recorded aided by rising rates, higher loan balances and strong fee income.
HBAN HBANN TCBIW HBANO HBANP TCBIP TCBI KO TCBIL BOKF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 044615010